KK-2260
- Generic Name
- KK-2260
A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors
- First Posted Date
- 2024-02-08
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 169
- Registration Number
- NCT06248411
- Locations
- 🇯🇵
Aichi Cancer Center Hospital, Nagoya, Aichi, Japan
🇯🇵Kobe University Hospital, Kobe, Hyogo, Japan
🇯🇵Shizuoka Cancer Center, Nagaizumi-cho, Shizuoka, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath